- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Osteopore Ltd H1 Sales Decline | 1 | RTTNews | ||
| Mo | OSTEOPORE LIMITED: Half Yearly Report and Accounts | 1 | ASX | ||
| 06.08. | Daily Special: Chilwa Minerals, Osteopore, DeSoto Resources, Sabre Resources, Somerset Minerals | 5 | Finance News Network | ||
| OSTEOPORE Aktie jetzt für 0€ handeln | |||||
| 06.08. | Osteopore (ASX:OSX) signs 3-year GCC deal targeting a US$1.55bn orthopaedic market | - | Stocks Down Under | ||
| 06.08. | OSTEOPORE LIMITED: OSX strikes orthopaedic deal for 5 Middle East countries | 1 | ASX | ||
| 03.08. | OSTEOPORE LIMITED: Details of Auditor Appointment/Resignation | - | ASX | ||
| 03.08. | OSTEOPORE LIMITED: OSX completes first Hainan custom orthopaedic implant | 1 | ASX | ||
| 31.07. | OSTEOPORE LIMITED: Activities Report June 2026 and Appendix 4C | 1 | ASX | ||
| 23.07. | OSTEOPORE LIMITED: Application for quotation of securities - OSX | - | ASX | ||
| 14.07. | OSTEOPORE LIMITED: First OSX custom orthopaedic implant delivered to Hainan | - | ASX | ||
| 07.07. | OSTEOPORE LIMITED: OSX & Zimmer gain craniofacial market access to Saudi Arabia | - | ASX | ||
| 02.07. | OSTEOPORE LIMITED: OSX completes co-development project for neurosurgical guide | - | ASX | ||
| 30.06. | OSTEOPORE LIMITED: First patient treated in OSX-PAH jaw reconstruction trial | - | ASX | ||
| 29.06. | OSTEOPORE LIMITED: First 2 patients treated in QCH cleft lip clinical trial | - | ASX | ||
| 26.06. | Osteopore wraps up recruitment into 3D printing support for cleft lip patients | 1 | The Market Online Australia | ||
| 26.06. | OSTEOPORE LIMITED: QCH cleft lip clinical study patient recruitment completed | - | ASX | ||
| 24.06. | OSTEOPORE LIMITED: OSX neuro products approved in a major centre in Thailand | - | ASX | ||
| 23.06. | OSTEOPORE LIMITED: Cleansing Notice | - | ASX | ||
| 23.06. | OSTEOPORE LIMITED: Notification regarding unquoted securities - OSX | - | ASX | ||
| 23.06. | OSTEOPORE LIMITED: Further Drawdown of T2 of the Redeemable Convertible Notes | - | ASX |
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,630 | -1,35 % | AKTIEN IM FOKUS: Zinsanstieg birgt Gefahren für sichere Aktienhäfen | FRANKFURT (dpa-AFX) - Steigende Zinsen an den Kapitalmärkten haben zum Wochenbeginn die Aktienkurse von als sichere Anlagen geltenden Unternehmen belastet. Dazu zählen unter anderen die Immobilienwerte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,220 | +1,61 % | Fresenius Medical Care: Stabilität in stürmischen Zeiten dank robustem Geschäftsmodell | ||
| SIEMENS HEALTHINEERS | 39,000 | +0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BILLIONTOONE | 99,50 | 0,00 % | Canaccord initiates BillionToOne stock coverage with buy rating | ||
| CARL ZEISS MEDITEC | 31,560 | -1,87 % | Vom Patent zum Umsatz: Wie Health-Tech-Innovationen den Milliardenmarkt Augengesundheit erreichen - und warum für Rise Nano Optics jetzt die entscheidende Phase beginnt | ||
| HEARTFLOW | 48,880 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,530 | 0,00 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,75 | +0,03 % | Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth? | ||
| SANARA MEDTECH | 34,740 | +0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,790 | +0,13 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 19,410 | -0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,580 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,730 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 25,930 | 0,00 % | Progyny stock price target maintained at $31 by Citizens on new offering | ||
| GENEDX | 85,98 | 0,00 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs |
OSTEOPORE LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OSTEOPORE LIMITED finden Sie auf Wallstreet Online.